GW Pharmaceuticals announce quarterly financial results

27th February 2019 Uncategorised 0

GW Pharmaceuticals has reported revenue growth of 67.5% for the fourth quarter, driven by demand for Epidiolex.

More: GW Pharmaceuticals announce quarterly financial results
Source: News